147 related articles for article (PubMed ID: 37670121)
1. To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer?
Farley C; Bassett R; Meric-Bernstam F; Bedrosian I; Caudle A; DeSnyder S; Hunt K; Kuerer H; Singh P; Sun S; Tamirisa N; Teshome M; Hwang RF
Ann Surg Oncol; 2023 Dec; 30(13):8327-8334. PubMed ID: 37670121
[TBL] [Abstract][Full Text] [Related]
2. Factors Influencing Non-sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer.
Sanders SB; Hoskin TL; Stafford AP; Boughey JC
Ann Surg Oncol; 2022 Nov; 29(12):7769-7778. PubMed ID: 35834142
[TBL] [Abstract][Full Text] [Related]
3. Should patients with hormone receptor-positive, HER2-negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib?
Williams AD; Ruth K; Shaikh SS; Vasigh M; Pronovost MT; Aggon AA; Porpiglia AS; Bleicher RJ
Cancer; 2024 Apr; 130(7):1052-1060. PubMed ID: 38018862
[TBL] [Abstract][Full Text] [Related]
4. Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer with One to Three Positive Sentinel Lymph Nodes.
Kantor O; Weiss A; Burstein HJ; Mittendorf EA; King TA
Ann Surg Oncol; 2022 Nov; 29(12):7674-7682. PubMed ID: 35763229
[TBL] [Abstract][Full Text] [Related]
5. Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases.
Zheng J; Cai S; Song H; Wang Y; Han X; Wu H; Gao Z; Qiu F
Medicine (Baltimore); 2018 Nov; 97(44):e13015. PubMed ID: 30383658
[TBL] [Abstract][Full Text] [Related]
6. Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology.
Davis J; Boughey JC; Hoskin TL; Day CN; Cheville JC; Piltin MA; Hieken TJ
Clin Breast Cancer; 2021 Oct; 21(5):458-465. PubMed ID: 33839043
[TBL] [Abstract][Full Text] [Related]
7. Factors that determine whether a patient receives completion axillary lymph node dissection after a positive sentinel lymph node biopsy for breast cancer in British Columbia.
Aslani N; Swanson T; Kennecke H; Woods R; Davis N
Can J Surg; 2011 Aug; 54(4):237-42. PubMed ID: 21651836
[TBL] [Abstract][Full Text] [Related]
8. Factors Predictive of Sentinel Lymph Node Involvement in Primary Breast Cancer.
Malter W; Hellmich M; Badian M; Kirn V; Mallmann P; Krämer S
Anticancer Res; 2018 Jun; 38(6):3657-3662. PubMed ID: 29848724
[TBL] [Abstract][Full Text] [Related]
9. Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
Stafford AP; Hoskin TL; Day CN; Sanders SB; Boughey JC
Ann Surg Oncol; 2022 Aug; 29(8):4740-4749. PubMed ID: 35451727
[TBL] [Abstract][Full Text] [Related]
10. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.
Dabbs DJ; Fung M; Landsittel D; McManus K; Johnson R
Breast J; 2004; 10(2):101-5. PubMed ID: 15009035
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation.
Takei H; Yoshida T; Kurosumi M; Inoue K; Matsumoto H; Hayashi Y; Higuchi T; Uchida S; Ninomiya J; Kubo K; Oba H; Nagai S; Tabei T
Int J Clin Oncol; 2013 Jun; 18(3):547-53. PubMed ID: 22588780
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
Choi SH; Barsky SH; Chang HR
Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
[TBL] [Abstract][Full Text] [Related]
14. Does ultrasound evaluation of the axilla increase the rate of axillary lymph node dissection in early stage clinically node negative breast cancer patients?
Vasigh M; Meshkati Yazd SM; Karoobi M; Hajebi R; Yazdankhah Kenari A
BMC Surg; 2022 Mar; 22(1):80. PubMed ID: 35241059
[TBL] [Abstract][Full Text] [Related]
15. Independent risk factors for axillary lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes.
Zhang W; Xu J; Wang K; Tang XJ; Liang H; He JJ
BMC Womens Health; 2020 Jul; 20(1):143. PubMed ID: 32646416
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.
Mittendorf EA; Hunt KK; Boughey JC; Bassett R; Degnim AC; Harrell R; Yi M; Meric-Bernstam F; Ross MI; Babiera GV; Kuerer HM; Hwang RF
Ann Surg; 2012 Jan; 255(1):109-15. PubMed ID: 22167004
[TBL] [Abstract][Full Text] [Related]
17. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.
Mamtani A; Patil S; Van Zee KJ; Cody HS; Pilewskie M; Barrio AV; Heerdt AS; Morrow M
Ann Surg Oncol; 2016 Oct; 23(11):3481-3486. PubMed ID: 27169771
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of sentinel lymph node biopsy prior to axillary lymph node dissection: the role of isolated tumor cells/micrometastases and multifocality/multicentricity-a retrospective study of 1214 breast cancer patients.
Schröder L; Fricker R; Stein RG; Rink T; Fitz H; Blasius S; Wöckel A; Müller T
Arch Gynecol Obstet; 2018 Jun; 297(6):1509-1515. PubMed ID: 29594495
[TBL] [Abstract][Full Text] [Related]
19. Subsequent axillary surgery after sentinel lymph node biopsy: results from the BreastSurgANZ Quality Audit 2006-2010.
Chong C; Walters D; de Silva P; Taylor C; Spillane A; Kollias J; Pyke C; Campbell I; Maddern G
Breast; 2013 Dec; 22(6):1215-9. PubMed ID: 24157405
[TBL] [Abstract][Full Text] [Related]
20. Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
Hennigs A; Köpke M; Feißt M; Riedel F; Rezai M; Nitz U; Moderow M; Golatta M; Sohn C; Schneeweiss A; Heil J
Breast Cancer Res Treat; 2019 Jan; 173(2):429-438. PubMed ID: 30315437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
